Analyst ratings
14 analysts have weighed in: a Strong Buy consensus: 11 buy calls against 0 sell, with an average 12-month price target of $637.92.
NASDAQ: UTHR · Drug Manufacturers - Specialty & Generic
Over the past week, United Therapeutics (UTHR) saw about 23 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 61% bullish but is at odds: News runs 78% bullish while X sits at just 43%. Wall Street is more constructive, with 11 of 14 analysts rating UTHR a buy.
There is little buzz around UTHR this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 79% buy share sits next to a crowd that ranges from X at 43% to News at 78%. No other tracker puts the two side by side.
14 analysts have weighed in: a Strong Buy consensus: 11 buy calls against 0 sell, with an average 12-month price target of $637.92.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is cooling and the 2 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 18 points above the crowd average of 61%, the professionals are more constructive than retail. The split is inside the crowd: News reads 78% bullish while X sits at 43%, a 35-point spread that single-source trackers miss.
Over the 30-day window, United Therapeutics (UTHR) buzz held subdued around 21.0 while the price drifted down 7.8% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 737K shares. Updated Sep 26, 2026. Over the last 7 trading days, UTHR lost 4.4%. Buzz activity in the recent week averaged 28.6 and was variable, swinging between 21.0 and 47.1. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 15 of the 18 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for UTHR and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live UTHR sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 26, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (11 / 3 / 0) |
| Crowd bullish (7d) | 61% |
| Avg price target | $637.92 |
| Most bullish source | News, 78% |
| Most bearish source | X, 43% |
| Sentiment spread | 35 pts |
| Mentions (7d) | 23 |
| Market cap | $20.25B |
| P/E · Forward P/E | 17.5 · 16.4 |
| EPS · Beta | $26.92 · 0.6 |
| Revenue (TTM) | $3.15B · 42% margin |
| Industry | Drug Manufacturers - Specialty & Generic |
Based on aggregated sentiment from X and News sources, United Therapeutics (UTHR) currently carries an Adanos hold signal with 54/100 conviction. The current cross-source average reads 61% bullish across 2 active sources. Those sources contribute 23 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
The crowd reads bullish on United Therapeutics (UTHR), averaging 61% bullish across 2 tracked sources over the last 7 days. The two ends of the range are News at 78% bullish and X at 43%, a 35-point spread. On the professional side, 11 of 14 analysts rate UTHR a buy.
Of the 14 analysts covering United Therapeutics (UTHR), 11 rate it a buy, 3 a hold and 0 a sell, for a strong buy consensus. The average price target is $637.92. That puts the street ahead of the crowd, which averages 61% bullish.
United Therapeutics (UTHR)'s cross-source average is bullish at 61% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish. News reads 78% bullish and x coverage is the most negative at 43% bullish. The combined signal points to broad mixed pressure with 54/100 conviction.
The cross-source average is bullish for United Therapeutics (UTHR) at 61% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish. The most bearish reading is x at 43% bullish. 3-day activity momentum is falling across X and News. The hold signal carries 54/100 conviction.
X is the dominant discussion channel with 14 mentions (61% of total volume). News contributes 9 mentions. The cross-source average is bullish at 61% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. UTHR's hold signal at 54/100 conviction reflects a bullish cross-source average at 61% bullish. Source readings are split: 1 source leans bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The UTHR sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key